福元医药：关于兰索拉唑肠溶胶囊获得药品注册证书的公告

Group 1 - The core point of the article is that Fuyuan Pharmaceutical has received the drug registration certificate for Lansoprazole enteric-coated capsules from the National Medical Products Administration, allowing the company to commence production of the drug [2] Group 2 - The approved specifications for the drug are 15mg and 30mg [2] - This approval represents a significant milestone for the company in expanding its product offerings in the pharmaceutical market [2] - The announcement was made on the evening of July 31 [2]